Biofrontera Pharma GmbH, Hemmelrather Weg 201, 51377 Leverkusen, Germany; Department of Animal Physiology, Ruhr-University, Universitätsstraße 150, Bochum, Germany.
Department of Animal Physiology, Ruhr-University, Universitätsstraße 150, Bochum, Germany.
Photodiagnosis Photodyn Ther. 2018 Mar;21:385-392. doi: 10.1016/j.pdpdt.2018.02.007. Epub 2018 Feb 7.
Topical photodynamic therapy (PDT) is a highly effective therapy especially for extended cancerized fields of the skin. Whenever extended fields are treated pain management is advisable. Light source mediated pain management can be performed by reducing fluence rates, as long as this does not compromise efficacy.
Two squamous cell carcinoma cell lines (A431 and SCC-13) were subjected to in vitro PDT using two different ALA concentrations and synthesis intervals and protoporphyrin IX (PpIX) synthesis was assessed. Two total light doses (6 J/cm and 37 J/cm) were applied at three different fluence rates and cell viability was measured using the MTS-test.
Both cell lines synthetized PpIX at different kinetics. A431 cells produced a maximum 28.6 nmol/l PpIX, while SCC-13 reached only a production of 8.7 nmol/l. Illumination reduced cell viability depending on PpIX content and light dose. When a lower light dose (6 J/cm) was applied, only the combination with the highest PpIX content was effective in A431 cells and no effect could be detected in SCC-13 cells. With a light dose of 37 J/cm, lower PpIX amounts became effective in A431 and cell death could be induced in SCC-13 cells. Light fluence rate had no differential effect in this setup.
In both, A431 and SCC-13 cells, total light dose is a key factor for photodynamic efficacy. Additionally, our results hint towards a threshold concentration of PpIX upon which a drastic loss of viability occurs. Light fluence rate in the analyzed range is not a limiting factor of photodynamic cytotoxicity. This may allow for the clinical implementation of low fluence rate protocols for pain management without compromising efficacy.
局部光动力疗法(PDT)是一种非常有效的治疗方法,尤其适用于皮肤的广泛癌变区域。只要不影响疗效,就应考虑对这些区域进行疼痛管理。可以通过降低辐照度来实现光源介导的疼痛管理,只要这不会影响疗效。
使用两种不同的 ALA 浓度和合成间隔,对两种鳞状细胞癌细胞系(A431 和 SCC-13)进行体外 PDT,并评估原卟啉 IX(PpIX)的合成。在三种不同的辐照度下应用两种总光剂量(6 J/cm 和 37 J/cm),并用 MTS 试验测量细胞活力。
两种细胞系均以不同的动力学合成 PpIX。A431 细胞产生的最大 PpIX 含量为 28.6 nmol/l,而 SCC-13 仅达到 8.7 nmol/l 的产量。光照会根据 PpIX 含量和光剂量降低细胞活力。当应用较低的光剂量(6 J/cm)时,只有与最高 PpIX 含量相结合的组合在 A431 细胞中有效,而在 SCC-13 细胞中则检测不到效果。当使用光剂量为 37 J/cm 时,较低的 PpIX 量在 A431 中变得有效,并且可以诱导 SCC-13 细胞中的细胞死亡。在这种设置下,光辐照度没有差异影响。
在 A431 和 SCC-13 细胞中,总光剂量是光动力疗效的关键因素。此外,我们的结果表明 PpIX 存在一个阈值浓度,超过该浓度会导致细胞活力急剧丧失。在分析的范围内,光辐照度不是光动力细胞毒性的限制因素。这可能允许在不影响疗效的情况下,临床实施低辐照度方案来进行疼痛管理。